Latest Breaking News On - பலதரப்பட்ட சங்கம் க்கு சைகடெலிக் ஆய்வுகள் - Page 3 : comparemela.com

Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology Numinus Wellness Inc. a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its fiscal third quarter results ended May 31, 2021 . In the third quarter, Numinus maintained a healthy cash position, achieved key milestones in its lab and proprietary portfolio, expanded the clinic network, and continued to advance its basic and clinical … Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its fiscal third quarter results ended May 31, 2021 .

United statesJohn fongPayton nyquvestNuminus bioscienceNeurology centerNuminus wellness incMultidisciplinary association for psychedelic studiesNuminus healthTrademark officeHealth canadaVenture exchangeRegulation services providerNuminus wellnessQuarter endUnited states patentMultidisciplinary association